| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Rheumatology,* the School of Clinical Medical Sciences, The Medical School, University of Newcastle, Newcastle upon Tyne, United Kingdom; and the Department of Pathology and Molecular Medicine, McMaster University, Ontario, Canada
Oncostatin M (OSM) is an interleukin (IL)-6 family cytokine that we have previously shown can synergize with a number of proinflammatory cytokines to promote the release of collagen from cartilage in explant culture. However, the effects of this potent cytokine combination in vivo are not known. Using adenoviral gene transfer, we have overexpressed murine IL-1 (AdmIL-1) and murine OSM (AdmOSM) intraarticularly in the knees of C57BL/6 mice. Histological analyses indicated marked synovial hyperplasia and inflammatory cell infiltration for both AdmIL-1 and AdmOSM but not in control joints. This inflammation was even more pronounced for the AdmIL-1+AdmOSM combination with evidence of cartilage and bone destruction. Significant loss of both proteoglycan and collagen was also seen for this combination, and immunohistochemistry revealed an increased expression of matrix metalloproteinases (MMPs) with decreased tissue inhibitor of metalloproteinases (TIMPs) in both articular cartilage and synovium. Similar expression profiles for MMPs/TIMPs were found in IL-1+OSM-stimulated human articular chondrocytes. Taken together, these data confirm that, in vivo, OSM can exacerbate the effects of IL-1 resulting in inflammation and tissue destruction characteristic of that seen in rheumatoid arthritis. We provide further evidence to implicate the up-regulation of MMPs as a key factor in joint pathology.
This article has been cited by other articles:
 |
|
 |
|
  G. J. Litherland, C. Dixon, R. L. Lakey, T. Robson, D. Jones, D. A. Young, T. E. Cawston, and A. D. Rowan Synergistic Collagenase Expression and Cartilage Collagenolysis Are Phosphatidylinositol 3-Kinase/Akt Signaling-dependent J. Biol. Chem., May 23, 2008; 283(21): 14221 - 14229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. D. Shingleton, D. Jones, X. Xu, T. E. Cawston, and A. D. Rowan Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes Rheumatology, August 1, 2006; 45(8): 958 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T G Morgan, A D Rowan, S C Dickinson, D Jones, A P Hollander, D Deehan, and T E Cawston Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor {alpha} by the release of collagen fragments via collagenases Ann Rheum Dis, February 1, 2006; 65(2): 184 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W Hui, H E Barksby, D A Young, T E Cawston, N McKie, and A D Rowan Oncostatin M in combination with tumour necrosis factor {alpha} induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2 Ann Rheum Dis, November 1, 2005; 64(11): 1624 - 1632. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
